Biologics not associated with COVID-19 risk or mortality

Biologics not associated with COVID-19 risk or mortality

COVID-19 mortality was not increased in patients on immunosuppressive biologics, according to a study.“The COVID-19 pandemic raised concerns about management of patients with immune-mediated inflammatory diseases treated with immunosuppressive biologics,” Vartan Pahalyants, MD, MBA, from the department of dermatology at Massachusetts General Hospital, and colleagues wrote.“As population level analyses of this patient group remain limited, we compared COVID-19 incidence and subsequent mortality in a large cohort of patients prescribed biologics and matched controls.”TheRead More

Share on facebook
Share on twitter
Share on linkedin